Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples